SLXN
Silexion Therapeutics Corp
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: ILExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 45 of Silexion Therapeutics Corp's SEC filings and found 22 warrant series, 1 convertible, 1 ATM program, 1 equity line, 4 shelf registrations, 6 S-1 registrations and 4 completed offerings on file for SLXN. The latest dilution event on file is an offering on Oct 28, 2026. Analysis updated Oct 29, 2026.
